Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $28.60, with a market capitalization of 162.81B. The stock trades at a price-to-earnings (P/E) ratio of 37.69 and offers a dividend yield of 6.04%.
On 2026-09-01, Pfizer(PFE) stock traded between a low of $28.46 and a high of $29.09. Shares are currently priced at $28.60, which is +0.5% above the low and -1.7% below the high.
The Pfizer(PFE)'s current trading volume is 42.49M, compared to an average daily volume of 35.6M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.09 and a 52-week low of $23.58.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.09 and a 52-week low of $23.58.
PFE News
Investing CFO Turnover at AT&T, Caterpillar, and Pfizer Sparked Rallies. Here’s Why Rivian’s Didn’t. Three blue-chip CFO swaps touched off double-digit stock ra...
Pfizer and BioNTech previously received FDA approval for their 2026–2027 COMIRNATY XFG mRNA COVID-19 vaccine, tailored to the XFG variant, for adults 65+ and hi...
Investing Pfizer and Starbucks: One Turnaround Is Built to Last, and One Isn’t Pfizer and Starbucks both raised their outlooks this summer, but a louder recover...
Analyst ratings
62%
of 29 ratingsMore PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer is quietly reshaping its pipeline, unveiling...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. is launching a new continuation study for tucatinib that focuses on patients...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a post‑marketing drug use study called “XALKORI ROS1+NSCLC D...
Investing BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat A single trial readout is reshuffling the mRNA vacci...
Priovant Therapeutics, a company backed by Pfizer (PFE) and Roivant Sciences (ROIV), has received FDA approval for its lead asset, Lisraya (brepocitinib), for d...
Investing Wall Street Is Sleeping on These 3 Ultra-High-Yield Dividend Stocks Three famous dividend names trade well below their five-year highs while their CEO...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. is reporting new data from its Korean post-marketing study of Vyndamax capsul...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.